|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Neurology/Neurosurgery Intensive Care Unit, and Department of Neurology, Brigham and Women's Hospital; and Harvard Medical School, Boston
2 From the Lund University School of Medicine, Lund, Sweden
3 From the and Harvard Medical School, Boston
4 From the Division of Nuclear Medicine, Beth Israel Hospital, Boston; and Harvard Medical School, Boston
5 From the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital; and Harvard Medical School, Boston
Study objectives: To determine the risk factors and frequency of intracranial hemorrhage among patients undergoing thrombolysis for pulmonary embolism.
Design: A retrospective descriptive and controlled analysis.
Setting: Hospitalized patients at centers in the United States, Canada, and Italy.
Patients: All had evidence of pulmonary embolism on perfusion scans or angiography.
Interventions: None.
Measurements and results: Data were analyzed on 312 patients from five previously reported studies of pulmonary embolism thrombolysis. The frequency of intracranial hemorrhage up to 14 days after pulmonary embolism thrombolysis was 6 of 312 or 1.9% (95% confidence interval, 0.7 to 4.1%). Two of six intracranial hemorrhages were fatal. Two of the six patients received thrombolysis in violation of the protocol because they had pre-existing, known intracranial disease. Average diastolic BP at the time of hospital admission was significantly elevated in patients who developed an intracranial hemorrhage (90.3±15.1 mm Hg) compared with those who did not (77.6±10.9 mm Hg; p=0.04). Other baseline characteristics and laboratory data were similar in both groups. Decreased level of consciousness, hemiparesis, and visual field deficits were the most common clinical signs of intracranial hemorrhage.
Conclusions: Intracranial hemorrhage after pulmonary embolism thrombolysis is an infrequent but often grave complication. Meticulous patient screening before administering thrombolysis is imperative. Diastolic hypertension at the time of hospital admission is a risk factor for intracranial hemorrhage after pulmonary embolism thrombolysis.
Key Words: intracranial hemorrhage hypertension pulmonary embolism thrombolytic therapy
Submitted on August 27, 1996
Accepted on December 5, 2007
This article has been cited by other articles:
![]() |
T Harris and S Meek When should we thrombolyse patients with pulmonary embolism? A systematic review of the literature Emerg. Med. J., November 1, 2005; 22(11): 766 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Thabut and D. Logeart Thrombolysis for Pulmonary Embolism in Patients With Right Ventricular Dysfunction: Con Arch Intern Med, October 24, 2005; 165(19): 2200 - 2203. [Full Text] [PDF] |
||||
![]() |
C. Dauphine and B. Omari Pulmonary Embolectomy for Acute Massive Pulmonary Embolism Ann. Thorac. Surg., April 1, 2005; 79(4): 1240 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Kreit The Impact of Right Ventricular Dysfunction on the Prognosis and Therapy of Normotensive Patients With Pulmonary Embolism Chest, April 1, 2004; 125(4): 1539 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism Thorax, June 1, 2003; 58(6): 470 - 483. [Full Text] [PDF] |
||||
![]() |
G. Thabut, D. Thabut, R. P. Myers, B. Bernard-Chabert, R. Marrash-Chahla, H. Mal, and M. Fournier Thrombolytic therapy of pulmonary embolism: A meta-analysis J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1660 - 1667. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Konstantinides, A. Geibel, G. Heusel, F. Heinrich, W. Kasper, and the Management Strategies and Prognosis of Pulmona Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism N. Engl. J. Med., October 10, 2002; 347(15): 1143 - 1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Wood Major Pulmonary Embolism : Review of a Pathophysiologic Approach to the Golden Hour of Hemodynamically Significant Pulmonary Embolism Chest, March 1, 2002; 121(3): 877 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.Z. Goldhaber Modern treatment of pulmonary embolism Eur. Respir. J., February 1, 2002; 19(35_suppl): 22S - 27s. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Z. Goldhaber Thrombolysis in Pulmonary Embolism: A Large-Scale Clinical Trial Is Overdue Circulation, December 11, 2001; 104(24): 2876 - 2878. [Full Text] [PDF] |
||||
![]() |
B. L. Davidson and A. W. A. Lensing Should Echocardiography of the Right Ventricle Help Determine Who Receives Thrombolysis for Pulmonary Embolism? Chest, July 1, 2001; 120(1): 6 - 8. [Full Text] [PDF] |
||||
![]() |
E. Hamel, G. Pacouret, D. Vincentelli, J. F. Forissier, P. Peycher, J. M. Pottier, and B. Charbonnier Thrombolysis or Heparin Therapy in Massive Pulmonary Embolism With Right Ventricular Dilation : Results From a 128-Patient Monocenter Registry Chest, July 1, 2001; 120(1): 120 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Z Goldhaber A contemporary approach to thrombolytic therapy for pulmonary embolism Vascular Medicine, May 1, 2000; 5(2): 115 - 123. [Abstract] [PDF] |
||||
![]() |
M. Procopiou, A. Perrier, F. Greco, and D. Guzzo Treatment of Right Heart Thromboemboli With IV Recombinant Tissue-Type Plasminogen Activator Chest, March 1, 2000; 117(3): 920 - 921. [Full Text] [PDF] |
||||
![]() |
W.-K. Chan and T.-F. Chan Thrombolysis for acute pulmonary embolism in Chinese patients QJM, February 1, 2000; 93(2): 125 - 127. [Full Text] [PDF] |
||||
![]() |
H. S. Blaustein, I. Schur, and J. M. Shapiro Acute Massive Pulmonary Embolism in a Jehovah’s Witness: Successful Treatment With Catheter Thrombectomy Chest, February 1, 2000; 117(2): 594 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Arcasoy and J. W. Kreit Thrombolytic Therapy of Pulmonary Embolism: A Comprehensive Review of Current Evidence Chest, June 1, 1999; 115(6): 1695 - 1707. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lick and V. Conti Thrombolysis With Resolution of Pulmonary Hypertension in a Heart Transplant Candidate Chest, March 1, 1999; 115(3): 896 - 897. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |